Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Cell-cycle arrest versus cell death in cancer therapy

Abstract

In response to anticancer therapeutics, human colon cancer cells growing in vitro either enter into a stable arrest or die, depending on the integrity of their cell-cycle checkpoints1. To test whether altered checkpoints can modulate sensitivity to treatment in vivo, xenografts were established from isogenic lines differing only in their p21 checkpoint status. Although all tumors with intact checkpoint function underwent regrowth after treatment with γ-radiation, a significant fraction of checkpoint-deficient tumors were completely cured. This difference in sensitivity was not detected by the clonogenic survival assay, because both arrest and death preclude outgrowth of colonies. These results demonstrate that checkpoint status affects sensitivity to anticancer treatments in vivo, and these findings have important implications for identifying and testing new therapeutic compounds.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Waldman, T., Lengauer, C., Kinzler, K.W. & Vogelstein, B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381, 713–716 (1996).

    Article  CAS  Google Scholar 

  2. Kastan, M.B., Onyekwere, O., Sidransky, D., Vogelstein, B. & Craig, R.W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51, 6304–6311 (1991).

    CAS  Google Scholar 

  3. Cross, S.M. et al. A p53-dependent mouse spindle checkpoint. Science 267, 1353–1356 (1995).

    Article  CAS  Google Scholar 

  4. Tishler, R.B., Lamppu, D.B., Park, S. & Price, B.D. Microtubule active drugs Taxol, vinblastine, and nocodazole increase the levels of transcriptionally active p53. Cancer Res. 55, 6021–6025 (1995).

    CAS  PubMed  Google Scholar 

  5. Linke, S.P., Clarkin, K.C., Di Leonardo, A., Tsou, A. & Wahl, G.M. A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev. 10, 934–947 (1996).

    Article  CAS  Google Scholar 

  6. Lowe, S.W., Ruley, H.E., Jacks, T. & Housman, D.E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74, 957–967 (1993).

    Article  CAS  Google Scholar 

  7. Hartwell, L.H. & Kastan, M.B. Cell cycle control and cancer. Science 266, 1821–1828 (1994).

    Article  CAS  Google Scholar 

  8. EI-Deiry, W. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817–825 (1993).

    Article  Google Scholar 

  9. Xiong, Y. et al. p21 is a universal inhibitor of cyclin kinases. Nature 366, 701–704 (1993).

    Article  CAS  Google Scholar 

  10. Harper, J.W., Adami, C.R., Wei, N., Keyomarsi, K. & Elledge, S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805–816 (1993).

    Article  CAS  Google Scholar 

  11. Waldman, T., Kinzler, K. & Vogelstein, B. p21 is necessary for the p53-mediated C1 arrest in human cancer cells. Cancer Res. 55, 5187–5190 (1995).

    CAS  Google Scholar 

  12. Deng, C., Zhang, P., Harper, J.W., Elledge, S.J. & Leder, P. Mice lacking P21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82, 675–684 (1995).

    Article  CAS  Google Scholar 

  13. Brugarolas, J. et al. Radiation-inducede cell cycle arrest compromised by p21 deficiency. Nature 377, 552–557 (1995).

    Article  CAS  Google Scholar 

  14. Di Leonardo, A., Linke, S.P., Clarkin, K. & Wahl, G.M. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev. 8, 2540–2551 (1994).

    Article  CAS  Google Scholar 

  15. Li, C., Nagasawa, H., Tsang, N. & Little, J.B. Radiation-induced irreversible G0/G1, block is abolished in human diploid fibroblasts transfected with human papilloma virus E6 gene: Implications of the p53-Cip1/WAF1 pathway. Int. J. Oncol. 6, 233–236 (1995).

    CAS  PubMed  Google Scholar 

  16. Revesz, L. Effect of tumour cells killed by x-rays upon the growth of admixed viable cells. Nature 178, 1391–1392 (1956).

    Article  CAS  Google Scholar 

  17. Revesz, L. Effect of lethally damaged tumor cells upon the development of admixed viable cells. J. Natl. Cancer Inst. 20, 1157–1186 (1958).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Waldman, T., Zhang, Y., Dillehay, L. et al. Cell-cycle arrest versus cell death in cancer therapy. Nat Med 3, 1034–1036 (1997). https://doi.org/10.1038/nm0997-1034

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0997-1034

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing